Pharmaceutical Legislation: An Historical Perspective
Download in electronic PDF format for $75
Abstract: Pharmaceutical quality and consistency has been a focus of pharmaceutical legislation in the United States for well over a century. The first such legislative initiative was the Drug Importation Act of 1848. It was the 1906 Pure Food and Drug Act, however, that first brought the issues of drug safety to the attention of the public. This law was the first to designate the United States Pharmacopeia and National Formulary as standards
for quality of drugs prepared in the US. Subsequent legislation and amendments addressed loopholes in this law, but it wasn't until the Food, Drug, and Cosmetic Act was passed in 1938 that fraudulent and misleading claims for pharmaceutical products were addressed. This essay describes each pharmaceutical legislative initiative in the context of pharmacy practice of the time.
Related Keywords:
Dennis B. Worthen, PhD, drug laws, pharmacy regulations, history, United States Pharmacopeia, National Formulary, pharmacy education
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Pharmaceutical Legislation: An Historical Perspective
Worthen Dennis B
|
Jan/Feb 2006
Pg. 20-28
|
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor
Allen Loyd V Jr
|
May/Jun 2004
Pg. 162
|
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 356
|
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
|
Nov/Dec 2015
Pg. 453-463
|
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
|
Jul/Aug 2013
Pg. 283-288
|
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014
Pg. 101-111
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 92
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
|
May/Jun 2020
Pg. 180
|
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
|
Mar/Apr 2021
Pg. 115-124
|
Art of Pharmacy v. State
Standridge Rob
|
May/Jun 2022
Pg. 182-186
|
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 4
|
Pharmacy History: Pharmacy Knots
Worthen Dennis B
|
May/Jun 2005
Pg. 220-221
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 146-150
|
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 356
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
American Pharmaceutical Patents From a Historical Perspective
Worthen Dennis B
|
Jan/Feb 2004
Pg. 40-45
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Kumar Anuj, Madan Anil K
|
Jul/Aug 2014
Pg. 293-300
|
| Return to Top |
